SK5972002A3 - Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent - Google Patents

Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent Download PDF

Info

Publication number
SK5972002A3
SK5972002A3 SK597-2002A SK5972002A SK5972002A3 SK 5972002 A3 SK5972002 A3 SK 5972002A3 SK 5972002 A SK5972002 A SK 5972002A SK 5972002 A3 SK5972002 A3 SK 5972002A3
Authority
SK
Slovakia
Prior art keywords
benzoic acid
methyl
piperazinyl
oxo
oxazolidinones
Prior art date
Application number
SK597-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Jackson B Hester Jr
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of SK5972002A3 publication Critical patent/SK5972002A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK597-2002A 1999-12-14 2000-12-06 Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent SK5972002A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17067599P 1999-12-14 1999-12-14
PCT/US2000/032432 WO2001044212A1 (en) 1999-12-14 2000-12-06 Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent

Publications (1)

Publication Number Publication Date
SK5972002A3 true SK5972002A3 (en) 2003-01-09

Family

ID=22620832

Family Applications (1)

Application Number Title Priority Date Filing Date
SK597-2002A SK5972002A3 (en) 1999-12-14 2000-12-06 Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent

Country Status (26)

Country Link
US (1) US6281210B1 (pt)
EP (1) EP1242395B1 (pt)
JP (1) JP2003516977A (pt)
KR (1) KR20020062332A (pt)
CN (1) CN1390211A (pt)
AR (1) AR026547A1 (pt)
AT (1) ATE288423T1 (pt)
AU (1) AU1805801A (pt)
BR (1) BR0015177A (pt)
CA (1) CA2387047A1 (pt)
CO (1) CO5261527A1 (pt)
CZ (1) CZ20022389A3 (pt)
DE (1) DE60017941T2 (pt)
EA (1) EA200200673A1 (pt)
ES (1) ES2236006T3 (pt)
HU (1) HUP0203787A3 (pt)
IL (1) IL150031A0 (pt)
MX (1) MXPA02005909A (pt)
NO (1) NO20022811D0 (pt)
PE (1) PE20010851A1 (pt)
PL (1) PL355369A1 (pt)
PT (1) PT1242395E (pt)
SK (1) SK5972002A3 (pt)
TW (1) TW544449B (pt)
WO (1) WO2001044212A1 (pt)
ZA (1) ZA200202953B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
ATE321024T1 (de) * 2000-10-17 2006-04-15 Pharmacia & Upjohn Co Llc Verfahren zur herstellung von oxazolidinonverbindungen
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
TW200403240A (en) * 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents
TW200404069A (en) * 2002-06-28 2004-03-16 Upjohn Co Difluorothioacetamides of oxazolidinones with a glycoloylpiperazine substituent
ATE344036T1 (de) 2002-11-21 2006-11-15 Pharmacia & Upjohn Co Llc N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinon-5- carbonsäureamid-derivate und verwandte verbindungen als antibakterielle mittel
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) * 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005045518A1 (de) * 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
CA2624310C (en) 2005-10-04 2014-01-07 Bayer Healthcare Ag Polymorphic form of 5-chloro-n-({5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide
WO2008073444A2 (en) * 2006-12-12 2008-06-19 The Johns Hopkins University Phou (perf), a persistence switch involved in persister formation as a drug target for persister bacteria
CA2692255A1 (en) * 2007-06-22 2008-12-31 Orchid Research Laboratories Limited Novel compounds and their use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995014684A1 (en) * 1993-11-22 1995-06-01 The Upjohn Company Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones
MY116093A (en) * 1996-02-26 2003-11-28 Upjohn Co Azolyl piperazinyl phenyl oxazolidinone antimicrobials
WO1998054161A1 (en) * 1997-05-30 1998-12-03 Pharmacia & Upjohn Company Oxazolidinone antibacterial agents having a thiocarbonyl functionality
GB9812019D0 (en) * 1998-06-05 1998-07-29 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
WO2001044212A1 (en) 2001-06-21
NO20022811L (no) 2002-06-13
NO20022811D0 (no) 2002-06-13
AU1805801A (en) 2001-06-25
ZA200202953B (en) 2003-09-23
HUP0203787A3 (en) 2005-06-28
CO5261527A1 (es) 2003-03-31
PE20010851A1 (es) 2001-08-17
EP1242395B1 (en) 2005-02-02
EA200200673A1 (ru) 2002-12-26
PL355369A1 (en) 2004-04-19
MXPA02005909A (es) 2002-10-23
DE60017941T2 (de) 2006-03-30
PT1242395E (pt) 2005-05-31
KR20020062332A (ko) 2002-07-25
EP1242395A1 (en) 2002-09-25
CZ20022389A3 (cs) 2002-10-16
CA2387047A1 (en) 2001-06-21
US6281210B1 (en) 2001-08-28
ES2236006T3 (es) 2005-07-16
ATE288423T1 (de) 2005-02-15
CN1390211A (zh) 2003-01-08
AR026547A1 (es) 2003-02-19
DE60017941D1 (de) 2005-03-10
JP2003516977A (ja) 2003-05-20
IL150031A0 (en) 2002-12-01
BR0015177A (pt) 2002-06-18
HUP0203787A2 (hu) 2003-07-28
TW544449B (en) 2003-08-01

Similar Documents

Publication Publication Date Title
ES2256331T3 (es) Derivados de quinolina antimicrobianos y uso de los mismos para tratar infecciones bacterianas.
EP0730591B1 (en) Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones
KR100340365B1 (ko) 옥사졸리디논유도체및이들을함유하는약학조성물
KR20020067557A (ko) 설폭시민 관능기를 가지는 옥사졸리디논 및항미생물제로서의 그의 용도
SK5972002A3 (en) Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent
MXPA02007719A (es) Tioamidas de oxazolidinona con sustituyentes de piperazina y amida.
US6642238B2 (en) Oxazolidinone thioamides with piperazine amide substituents
JP5662940B2 (ja) 新規な抗微生物薬
US20090137553A1 (en) Thiazepine Oxazolidinones as Antibacterial Agents
US20040127530A1 (en) Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
US7592335B2 (en) Oxazolidinone derivatives as antimicrobials
JP2008521792A (ja) 抗菌薬としてのジアゼピンオキサゾリジノン
EP2032565A2 (en) Benzisoxazole oxazolidinones as antibacterial agents
WO2007088478A1 (en) Indazole oxazolidinones as antibacterial agents
US6348459B1 (en) Sultam and sultone derived oxazolidinones

Legal Events

Date Code Title Description
FB9A Suspension of patent application procedure